Act Capital Management, LLC Clearside Biomedical, Inc. Transaction History
Act Capital Management, LLC
- $72.5 Million
- Q3 2022
A detailed history of Act Capital Management, LLC transactions in Clearside Biomedical, Inc. stock. As of the latest transaction made, Act Capital Management, LLC holds 2,197,480 shares of CLSD stock, worth $2.55 Million. This represents 3.43% of its overall portfolio holdings.
Number of Shares
2,197,480
Previous 2,288,200
3.96%
Holding current value
$2.55 Million
Previous $3.36 Million
26.19%
% of portfolio
3.43%
Previous 4.7%
Shares
6 transactions
Others Institutions Holding CLSD
# of Institutions
53Shares Held
13.4MCall Options Held
17.6KPut Options Held
100-
Vanguard Group Inc Valley Forge, PA2.84MShares$3.29 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY2.14MShares$2.48 Million0.04% of portfolio
-
Carmignac Gestion Paris, I02.13MShares$2.47 Million0.05% of portfolio
-
Black Rock Inc. New York, NY798KShares$925,8380.0% of portfolio
-
Geode Capital Management, LLC Boston, MA672KShares$779,8640.0% of portfolio
About Clearside Biomedical, Inc.
- Ticker CLSD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,190,700
- Market Cap $69.8M
- Description
- Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...